General Information
Mylan DM 1 3004
“A Randomized, Multi-center, Double-Blind, Parallel-Group Clinical Study Comparing the Efficacy and Safety of MYL-1501D Produced by Two Manufacturing Processes in Type 1 Diabetes Mellitus Patients
| Protocol | MYL-1501D-3004 |
|---|---|
| Identifier | |
| UID | 70b1fef6-6c02-471b-90ee-7152c060fd6f |
| Status | Done - Archived |
| Phase | 3 |
| Category | Diabetes Type 1 / Adult |
| Launch Year | 2018 |
| NCT Number | - |
| Created | 2017-10-20 17:25 |
| Last Updated | 2017-10-20 17:25 |
Description
No description provided.
Comment
CRI
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2018-03-28 | No |
| Enrollment Open | 2018-02-20 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2018-02-20 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2018-11-14 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Unger, Jeffrey | JUnger | No |
| Recruiter | Miss, Salomon | SMiss | No |
| Coordinator | Rocha, Luis | LRocha | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Mylan |
|---|---|
| Division | Mylan |
| Team | Mylan |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | IQVIA RDS Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
